-
Founded in:
1992-08-12 -
Country:
China -
Address:
No. 366, Anping Road, Zhaobaoshan Street, Zhenhai District, Ningbo City, Zhejiang Province -
Tax NO.:
91330211144072003N -
Registered Funds:
415 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pyrazinamide |
It has a good antibacterial effect on human tuberculosis bacteria, and its bactericidal effect is strongest at pH 5-5.5. It is currently the best bactericidal drug for tuberculosis bacteria that grow slowly in phagocytes in an acidic environment. The antibacterial concentration in vivo is 12.5μg/ml, and 50μg/ml can kill tuberculosis bacteria. The concentration that inhibits tuberculosis bacteria inside cells is 10 times lower than that outside cells, and it has almost no antibacterial effect in neutral and alkaline environments. The mechanism of action may be related to pyrazinoic acid, which interferes with dehydrogenase by replacing nicotinamide, prevents dehydrogenation, hinders the use of oxygen by tuberculosis bacteria, affects the normal metabolism of bacteria, and causes death.
More
It has a good antibacterial effect on human tuberculosis bacteria, and its bactericidal effect is strongest at pH 5-5.5. It is currently the best bactericidal drug for tuberculosis bacteria that grow slowly in phagocytes in an acidic environment. The antibacterial concentration in vivo is 12.5μg/ml, and 50μg/ml can kill tuberculosis bacteria. The concentration that inhibits tuberculosis bacteria inside cells is 10 times lower than that outside cells, and it has almost no antibacterial effect in neutral and alkaline environments. The mechanism of action may be related to pyrazinoic acid, which interferes with dehydrogenase by replacing nicotinamide, prevents dehydrogenation, hinders the use of oxygen by tuberculosis bacteria, affects the normal metabolism of bacteria, and causes death. |
98-96-4 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nimodipine |
Nimodipine is a Ca2 channel blocker that inhibits smooth muscle contraction and relieves vascular spasm by preventing Ca2 from entering cells. It has a strong effect on cerebral arteries and can penetrate the blood-brain barrier to prevent vascular spasm after subarachnoid hemorrhage, protect and promote memory, promote intellectual recovery, selectively act on cerebral vascular smooth muscle, dilate cerebral blood vessels, increase cerebral blood flow, and reduce ischemic brain damage.
More
Nimodipine is a Ca2 channel blocker that inhibits smooth muscle contraction and relieves vascular spasm by preventing Ca2 from entering cells. It has a strong effect on cerebral arteries and can penetrate the blood-brain barrier to prevent vascular spasm after subarachnoid hemorrhage, protect and promote memory, promote intellectual recovery, selectively act on cerebral vascular smooth muscle, dilate cerebral blood vessels, increase cerebral blood flow, and reduce ischemic brain damage. |
66085-59-4 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Albuterol sulfate |
Mainly acts on bronchial adrenergic receptors to relax smooth muscles
More
Mainly acts on bronchial adrenergic receptors to relax smooth muscles |
2.4mg | 51022-70-9 | 41 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Etamsylate |
It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.
More
It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect. |
2624-44-4 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ondansetron hydrochloride |
This product is a highly selective 5-hydroxytryptamine 3 (5-HT3) receptor antagonist that can inhibit nausea and vomiting caused by chemotherapy and radiotherapy. Its mechanism of action is not yet fully understood. It is generally believed that chemotherapy and radiotherapy can cause the chromaffin cells in the small intestine to release 5-HT3, and cause vagal afferent nerve excitement through 5-HT3 receptors, leading to vomiting reflex, and ondansetron can block this reflex.
More
This product is a highly selective 5-hydroxytryptamine 3 (5-HT3) receptor antagonist that can inhibit nausea and vomiting caused by chemotherapy and radiotherapy. Its mechanism of action is not yet fully understood. It is generally believed that chemotherapy and radiotherapy can cause the chromaffin cells in the small intestine to release 5-HT3, and cause vagal afferent nerve excitement through 5-HT3 receptors, leading to vomiting reflex, and ondansetron can block this reflex. |
103639-04-9 | 26 |